Summary of Awards

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Kathleen Brown, M.D..
Efficacy of a Community Program in Increasing Access to STAR

1.5

$47,445

$11,861

$59,306

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Richard Neve, Ph.D.
Molecular Characterization of ErbB2 Positive Breast Cancers

2.0

$80,000

$6,400

$86,400

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Nadeem Moghal, Ph.D.
Genetic Analysis of ErbB Signaling in C. Elegans

2.0

$80,000

$6,400

$86,400

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Pierre-Yves Desprez, Ph.D.
Role of Id-2 in Breast Cancer and its Relationship to Id-1

2.0

$190,457

$106,084

$296,541

Daryl Drummond, Ph.D.
Enhanced HER-2 Directed Liposomal Therapeutics

3.0

$299,913

$165,269

$465,182

Ellen Levine, Ph.D., M.P.H.
Child's Stress During Mother's Treatment for Breast Cancer

1.5

$100,000

$29,000

$129,000

SUBTOTAL

$590,370

$300,353

$890,723

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Dalia Ducker, Ph.D.
Child's Stress During Mother's Treatment for Breast Cancer

1.5

Collaborative Award

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Shikha Bose, M.D.
The PTEN/Akt Pathway in Ductal Carcinoma In Situ

1.0

$100,000

$0

$100,000

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Heidi Kleiger
Breast Cancer Prevention and Control Among Deaf Women

1.5

Collaborative Award

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Lola Sablan-Santos
A Network-Based Intervention for Chamorros in Southern California

3.0

$293,437

$73,359

$366,796

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Syed Ashraf Imam, Ph.D.
Early Detection of Breast Cancer and it Recurrence

2.0

$249,212

$116,234

$365,446

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Dave Hoon, M.Sc., Ph.D.
Clinical Utility of Breast Cancer DNA Markers in Serum

2.0

$250,000

$222,000

$472,000

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Ingrid Schraufstatter, M.D.
Are EGF-Receptors Activated by IL-8 In Breast Cancer?

1.0

$75,000

$80,475

$155,475

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Patrick Kaminker, Ph.D.
Telomere Clustering is Lost in Mammary Epithelial Tumors

2.0

$80,000

$0

$80,000

Sahn-Ho Kim, Ph.D.
Telomere Dynamics during Breast Development

1.0

$100,000

$57,715

$157,715

Yi-Ching Lio, Ph.D.
The Functions of BRCA2 in Repairing DNA Damage

3.0

$300,000

$195,388

$495,388

John Muschler, Ph.D.
Tumor Suppression by Dystroglycan in Breast Epithelial Cells

1.5

$200,000

$128,214

$328,214

Rana Zahedi, Ph.D.
Analysis of a Protease Involved in Mammary Development

2.0

$80,000

$0

$80,000

SUBTOTAL

$760,000

$381,317

$1,141,317

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Stavros Demos, Ph.D.
Optical Spectroscopic Detection and Imaging of Breast Cancer

1.5

$99,937

$49,730

$149,667

Michelle Bennett, Ph.D.
Evaluation of Essiac Tea to Prevent Mammary Tumors

1.5

$99,810

$85,832

$185,642

SUBTOTAL

$199,747

$135,562

$335,309

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Esther John, Ph.D.
Migration and Breast Cancer Risk in Hispanics

3.0

$745,320

$252,606

$997,926

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Gurucharan Reddy, Ph.D.
Novel Inhibitors of Rad51-DNA Repair in Breast Cancer

1.0

$73,220

$57,112

$130,332

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Paul Mills, Ph.D.
Pesticides and Breast Cancer in Hispanic Women

3.0

$263,488

$46,900

$310,388

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Zhiyong Wang, Ph.D.
Coactivators in Mammary Gland Development and Tumorigenesis

2.0

$80,000

$6,400

$86,400

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Masaaki Hayashi, M.D., Ph.D.
The Role of SGK in Breast Cancer Proliferation

2.0

$80,000

$6,400

$86,400

Yi Hsing Lin, Ph.D.
Lasp-1 Signaling in Breast Carcinoma Cell Invasion/Migration

2.0

$80,000

$6,400

$86,400

SUBTOTAL

$160,000

$12,800

$172,800

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Margaret Huflejt, Ph.D.
Targeting of Tumor-Promoting Galectins in Breast Cancer

1.0

$100,000

$82,500

$182,500

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Brian Murphy, Ph.D.
PPARd Ligands for Inhibition of Breast Cancer Progression

1.0

$200,000

$173,535

$373,535

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Kathie Dalessandri, M.D.
Dietary Indole Effect on Estrogen Urinary Metabolites

1.0

Collaborative Award

Anne-Renee Hartman, M.D.
The Role of BRCA1 in Nucleotide Excision Repair

2.0

$80,000

$6,400

$86,400

Quan Lu, Ph.D.
Genes that Modulate Dioxin-Induced Breast Cancer

2.0

$80,000

$6,400

$86,400

David Spiegel, M.D.
Does a Peer Navigator Improve Quality of Life at Diagnosis?

3.0

$556,172

$197,483

$753,655

Irene Wapnir, M.D.
Selective Targeting of Breast Cancer with Radioiodide

2.0

$200,000

$115,200

$315,200

Dawn Yean, Ph.D.
Regulation of the ATR Checkpoint Response in Breast Cancer

2.0

$80,000

$6,400

$86,400

SUBTOTAL

$996,172

$331,883

$1,328,055

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Klara Briknarova, Ph.D.
Molecular Study of BAG Domains: A New Motif in Breast Cancer

2.0

$80,000

$6,400

$86,400

Sharon James, Ph.D.
Protein Factor PPARγ and Vitamin A Compounds in Breast Cancer

2.0

$80,000

$6,400

$86,400

Kazuya Okada, M.D., Ph.D.
SBP-1: A Novel Surviving Binding Protein in Breast Cancer

2.0

$80,000

$6,400

$86,400

Elena Pasquale, Ph.D.
Targeting the EphB4 Receptor to Inhibit Breast Tumor Growth

1.0

$96,637

$94,704

$191,341

Marko Rehn, Ph.D.
P132Cas and Antiestrogen Resistance of Breast Cancer

2.0

$80,000

$6,400

$86,400

Erkki Ruoslahti, M.D., Ph.D.
Blood Vessel Markers in Breast Cancer

2.0

$199,549

$195,558

$395,107

Kristiina Vuori, M.D. Ph.D.
Overcoming Drug Resistance in Breast Cancer

2.0

$198,183

$194,220

$392,403

SUBTOTAL

$814,369

$510,082

$1,324,451

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Mitch Golant, Ph.D.
Effectiveness of Internet vs. Face to Face Support Groups

3.0

$224,445

$93,594

$318,039

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Leonard Bjeldanes, Ph.D.
Dietary Indole Effect on Estrogen Urinary Metabolites

1.0

Collaborative Award

Gary Firestone, Ph.D.
Dietary Indole Effect on Estrogen Urinary Metabolites

1.0

$89,925

$0

$89,925

Satyabrata Nandi, Ph.D.
Rodent Model for Human Ductal Carcinoma in Situ

1.0

$100,000

$0

$100,000

SUBTOTAL

$189,925

$0

$189,925

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

John Boone, Ph.D.
Breast CT for Much Earlier Detection of Breast Cancer

3.0

$500,000

$0

$500,000

Hongwu Chen, Ph.D.
Role of Chromatin Regulator in Breast Cell Growth

3.0

$286,151

$0

$286,151

Helen Chew, M.D.
LPC as a Potential Tumor Marker for Recurrent Breast Cancer

1.5

$100,000

$0

$100,000

Karen Lindfors, M.D.
Breast CT for Much Earlier Detection of Breast Cancer

3.0

$0

$0

$0

Susan Murin, M.D.
Smoking Effect on Pulmonary Metastasis from Breast Cancer

1.0

$75,000

$0

$75,000

Rajen Ramsamooj, M.D.
Optical Spectroscopic Detection and Imaging of Breast Cancer

1.0

$33,866

$0

$33,866

Colleen Sweeney, Ph.D.
Pathway-Specific Gene Expression in Breast Cancer Cells

3.0

$299,287

$0

$299,287

SUBTOTAL

$1,294,304

$0

$1,294,304

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Edward Nelson, M.D.
A New Genetic Vaccine Therapy for Breast Cancer

1.0

$100,000

$0

$100,000

Sora Tanjasiri, Dr.PH.
A Network-Based Intervention for Chamorros in Southern California

3.0

$206,214

$0

$206,214

SUBTOTAL

$306,214

$0

$306,214

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Barbara Berman, Ph.D
Breast Cancer Prevention and Control Among Deaf Women

1.5

$109,707

$0

$109,707

Pamela Davidson, Ph.D.
Geographic Variation in Breast Cancer Stage at Diagnosis

3.0

$425,497

$0

$425,497

Patricia Ganz, M.D.
Efficacy of a Community Program in Increasing Access to STAR

1.5

$68,350

$0

$68,350

Katherine Kahn, M.D.
The Impact of Structure on Quality of Breast Cancer Care

3.0

$851,916

$0

$851,916

Rose Maly, M.D., M.S.P.H.
Determinants of Breast Cancer Treatment in the Underserved

3.0

$870,038

$0

$870,038

Daniel Silverman, M.D., Ph.D.
Patient-Individualized Chemotherapy in Breast Cancer

3.0

$296,994

$0

$296,994

Michael Albert Thomas, Ph.D.
Breast Cancer Imaging by 2-D Magnetic Resonance Spectroscopy

2.0

$249,137

$0

$249,137

Nathaniel Wyckoff, Ph.D.
2-D Magnetic Resonance Spectroscopy of Breast Tumors

2.0

$80,000

$0

$80,000

SUBTOTAL

$2,951,639

$0

$2,951,639

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Kathryn DeFea, Ph.D.
Trypsin-like Proteases as Metastatic Agents in Breast Cancer

3.0

$295,980

$0

$295,980

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Wayne Bardwell, Ph.D.
Women with Breast Cancer: Quality of Life and Diet Adherence

3.0

$164,427

$0

$164,427

Randall Johnson, Ph.D.
Genetic Aspects of Physiological Response During Lactation

3.0

$593,997

$0

$593,997

Michael Karin, Ph.D.
Role of IKKa in Mammary Gland Development

3.0

$563,696

$0

$563,696

SUBTOTAL

$1,322,120

$0

$1,322,120

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Michael Campbell, Ph.D.
In Vivo Effects of Chinese Herbal Extracts on Breast Cancer

2.0

$200,000

$0

$200,000

Rani Eversley, Ph.D.
Return to Work after Breast Cancer Surgery

3.0

Collaborative Award

Morton Lieberman, Ph.D.
Effectiveness of Internet vs. Face to Face Support Groups

3.0

$268,554

$0

$268,554

Steven Rosen, Ph.D.
Novel Enzymes Associated with Breast Cancer Angiogensis

1.5

$100,000

$0

$100,000

Fred Schaufele, Ph.D.
Novel Technologies to Identify Tissue-Selective Estrogens

1.0

$75,000

$0

$75,000

Jeonghoon Sun, Ph.D.
Engineering Antibodies Specific for Breast Cancer Proteases

1.0

$80,000

$0

$80,000

Debasish Tripathy, M.D. Herba Scutellaria Barbatae for Metastatic Breast Cancer

2.0

$232,364

$0

$232,364

SUBTOTAL

$955,918

$0

$955,918

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Sue Ann Ingles, Dr.P.H.
Dietary Fat, Fat Metabolizing Genes and Breast Cancer Risk

2.0

$247,399

$139,279

$386,618

Michael Press, M.D., Ph.D.
HER-2/neu Gene Variations and Breast Cancer Risk

3.0

$706,175

$441,360

$1,147,535

SUBTOTAL

$953,514

$580,639

$1,534,153

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Caroline Bliss-Isberg, Ph.D.
Does a Peer Navigator Improve Quality of Life at Diagnosis?

3.0

Collaborative Award

INSTITUTION / PI / TITLE

DURATION

DIRECT COST

INDIRECT COST

TOTAL

Diane Estrin
Return to Work after Breast Cancer Surgery

3.0

$500,000

$125,000

$625,000